P503 Two year experience with vedolizumab in inflammatory bowel disease patients: results of the ICC case series, a nationwide prospective observational cohort study

Authors :: Jeoffrey J L Haans
Marie J. Pierik
A C de Vries
N de Boer
A. van der Meulen-de Jong
Johan F.G.A. Jansen
Rachel West
F. Hoentjen
Gerard Dijkstra
J. van der Woude
Mark Löwenberg
Vince B. C. Biemans
Bas Oldenburg
Nidhi Srivastava
Source :: Journal of Crohn's and Colitis. 13:S363-S364
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: medicine.medical_specialty
Series (stratigraphy)
business.industry
Internal medicine
Gastroenterology
medicine
General Medicine
business
medicine.disease
Inflammatory bowel disease
Vedolizumab
medicine.drug
Cohort study

Full Text Access

Tools